CHAPTER Ins 3500  VALUATION OF LIFE INSURANCE POLICIES

 

Statutory Authority:  RSA 400-A:15, I.; RSA 410

 

PART Ins 3501  PURPOSE

 

          Ins 3501.01  Purpose.

 

          (a)  The purpose of this rule is to provide:

 

(1)  Tables of select mortality factors and rules for their use;

 

(2)  Rules concerning a minimum standard for the valuation of plans with nonlevel premiums or benefits; and

 

(3)  Rules concerning a minimum standard for the valuation of plans with secondary guarantees.

 

          (b)  The method for calculating basic reserves defined in this rule will constitute the commissioner’s reserve valuation method for policies to which this rule is applicable.

 

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

PART Ins 3502  APPLICABILITY

 

          Ins 3502.01  Applicability.

 

          (a)  This rule shall apply to all life insurance policies, with or without nonforfeiture values, issued on or after the 2017 effective date of this rule, subject to the following exceptions and conditions:

 

(1)  Exceptions are:

 

a.  This rule shall not apply to any individual life insurance policy issued on or after the 2017 effective date of this rule if the policy is issued in accordance with and as a result of the exercise of a reentry provision contained in the original life insurance policy of the same or greater face amount, issued before the 2017 effective date of this rule, that guarantees the premium rates of the new policy.  This rule also shall not apply to subsequent policies issued as a result of the exercise of such a provision, or a deviation of the provision, in the new policy;

 

b.  This rule shall not apply to any universal life policy that meets all the following requirements:

 

1.  Secondary guarantee period, if any, is 5 years or less;

 

2.  Specified premium for the secondary guarantee period is not less than the net level reserve premium for the secondary guarantee period based on the 1980 CSO valuation tables as defined in Part Ins 3503 and the applicable valuation interest rate; and

 

3.  The initial surrender charge is not less than 100 percent of the first year annualized specified premium for the secondary guarantee period;

 

c.  This rule shall not apply to any variable life insurance policy that provides for life insurance, the amount or duration of which varies according to the investment experience of any separate account or accounts;

 

d.  This rule shall not apply to any variable universal life insurance policy that provides for life insurance, the amount or duration of which varies according to the investment experience of any separate account or accounts; and

 

e.  This rule shall not apply to a group life insurance certificate unless the certificate provides for a stated or implied schedule of maximum gross premiums required in order to continue coverage in force for a period in excess of one year.

 

(2)  Conditions are:

 

a.  Calculation of the minimum valuation standard for policies with guaranteed nonlevel gross premiums or guaranteed nonlevel benefits, other than universal life policies, or both, shall be in accordance with the provisions of Ins 3506; and

 

b.  Calculation of the minimum valuation standard for flexible premium and fixed premium universal life insurance policies, that contain provisions resulting in the ability of a policyholder to keep a policy in force over a secondary guarantee period shall be in accordance with provisions of  Ins 3506.

 

          (b)  In addition to the exceptions and conditions set out in (a) above, the commissioner, upon the commissioner’s own initiative or upon request by an insurer, shall waive any requirement of this chapter if such waiver does not contradict the objective or intent of the rule and: 

 

(1)  Applying the rule provision would cause confusion or would be misleading to consumers;

 

(2)  The rule provision is in whole or in part inapplicable to the specific circumstances;

 

(3)  There are specific circumstances unique to the situation such that strict compliance with the rule would be onerous without promoting the objective or intent of the rule provision; or

 

(4)  Any other similar extenuating circumstances exist such that application of an alternative standard or procedure better promotes the objective or intent of the rule provision; and

 

(5)  No requirement prescribed by statute shall be waived unless expressly authorized by law; and

 

(7)  Any request for a waiver shall be in writing and shall specify the basis for the waiver and proposed alternative, if any.

 

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

PART Ins 3503  DEFINITIONS

 

          Ins 3503.01  Definitions.

 

          (a)  “Basic reserves” means reserves calculated in accordance with RSA 410:4, Standard Valuation Law.

 

          (b)  “Contract segmentation method” means the method of dividing the period from issue to mandatory expiration of a policy into successive segments, with the length of each segment being defined as the period from the end of the prior segment (from policy inception, for the first segment) to the end of the latest policy year as determined below.  All calculations are made using the 1980 CSO valuation tables as defined in Ins 3503.01(f), (or any other valuation mortality table adopted by the National Association of Insurance Commissioner (NAIC) after the 2017 effective date of this rule and promulgated by rule by the commissioner for this purpose), and, if elected, the optional minimum mortality standard for deficiency reserves stipulated in Ins 3505.02 of this rule.

 

(1)  The length of a particular contract segment shall be set equal to the minimum of the value t for which Gt  is greater than Rt  (if Gt  never exceeds Rt  the segment length is deemed to be the number of years from the beginning of the segment to the mandatory expiration date of the policy), where Gt  and Rt  are defined as follows:

 

Gt  =         GPx+k+t

GPx+k+t-1

 

where:

 

        x =  original issue age;

 

        k =  the number of years from the date of issue to the beginning of the segment;

 

        t =  1,2,....; t is reset to 1 at the beginning of each segment;

 

GPx+k+t-1 =  Guaranteed gross premium per thousand of face amount for year t of the segment,

        ignoring policy fees only if level for the premium paying period of the policy.

 

        Rt =  qx+k+t

                qx+k+t-1 ,      However, Rt  may be increased or decreased by one percent

in any policy year, at the company’s option, but Rt , shall not be

less than one;

 

where:

 

x, k and t are as defined above, and

 

qx+k+t-1 =           valuation mortality rate for deficiency reserves in policy year k+t

but using the mortality of Ins 3504.02(a)(2) if Ins 3504.02(a)(3) is elected for deficiency reserves.

 

However, if GPx+k+t  is greater than 0 and GPx+k+t-1 is equal to 0, Gt  shall be deemed to be 1000.  If GPx+k+t  and GPx+k+t-1 are both equal to 0, Gt  shall be deemed to be 0.

 

          (c)  “Deficiency reserves” means the excess, if greater than zero, of:

 

(1)  Minimum reserves calculated in accordance with RSA 410:7, Standard Valuation Law, over

 

(2)  Basic reserves.

 

          (d)  “Guaranteed gross premiums” means the premiums under a policy of life insurance that are guaranteed and determined at issue.

 

          (e)  “Maximum valuation interest rates” means the interest rates in RSA 410:3-b, Standard Valuation Law, (Interest Rates), that are to be used in determining the minimum standard for the valuation of life insurance policies.

 

          (f)  “1980 CSO valuation tables” means the Commissioners’ 1980 Standard Ordinary Mortality Table (1980 CSO Table) without ten-year selection factors, incorporated into the 1980 amendments to the NAIC Standard Valuation Law, and variations of the 1980 CSO Table approved by the NAIC, such as the smoker and nonsmoker versions approved in December 1983.  These tables are available as referenced in Appendix B.

 

          (g)  “Scheduled gross premium” means the smallest illustrated gross premium at issue for other than universal life insurance policies.  For universal life insurance policies, scheduled gross premium means the smallest specified premium described in Ins 3506.01(c), if any, or else the minimum premium described in Ins 3506.01(d).

 

          (h)  “Segmented reserves” means reserves, calculated using segments produced by the contract segmentation method, equal to the present value of all future guaranteed benefits less the present value of all future net premiums to the mandatory expiration of a policy, where the net premiums within each segment are a uniform percentage of the respective guaranteed gross premiums within the segment and:

 

(1)  The uniform percentage for each segment is such that, at the beginning of the segment, the present value of the net premiums within the segment equals:

 

a.  The present value of the death benefits within the segment, plus;

 

b.  The present value of any unusual guaranteed cash value (see Ins 3505.04) occurring at the end of the segment, less;

 

c.  Any unusual guaranteed cash value occurring at the start of the segment, plus;

 

d.  For the first segment only, the excess of Item a. over Item b. as follows:

 

1.  A net level annual premium equal to the present value, at the date of issue, of the benefits provided for in the first segment after the first policy year, divided by the present value, at the date of issue, of an annuity of one per year payable on the first and each subsequent anniversary within the first segment on which a premium falls due.  However, the net level annual premium shall not exceed the net level annual premium on the nineteen-year premium whole life plan of insurance of the same renewal year equivalent level amount at an age one year higher than the age at issue of the policy; and

 

2.  A net one year term premium for the benefits provided for in the first policy year;

 

(2)  The length of each segment is determined by the “contract segmentation method”, as defined in this section;

 

(3)  The interest rates used in the present value calculations for any policy may not exceed the maximum valuation interest rate, determined with a guarantee duration equal to the sum of the lengths of all segments of the policy; and

 

(4)  For both basic reserves and deficiency reserves computed by the segmented method, present values shall include future benefits and net premiums in the current segment and in all subsequent segments.

 

          (i)  “Tabular cost of insurance” means the next single premium at the beginning of a policy year for one-year term insurance in the amount of the guaranteed death benefit in that policy year.

 

          (j)  “Ten-year select factors” means the select factors adopted with the 1980 amendments to the NAIC Standard Valuation Law.

 

          (k)  “Unitary reserves” means the present value of all future guaranteed benefits less the present value of all future modified net premiums, where:

 

(1)  Guaranteed benefits and modified net premiums are considered to the mandatory expiration of the policy;

 

(2)  Modified net premiums are a uniform percentage of the respective guaranteed gross premiums, where the uniform percentage is such that, at issue, the present value of the net premiums equals the present value of all death benefits and pure endowments, plus the excess of Item a. over Item b., as follows:

 

a.  A net level annual premium equal to the present value, at the date of issue, of the benefits provided for after the first policy year, divided by the present value, at the date of issue, of an annuity of one per year payable on the first and each subsequent anniversary of the policy on which a premium falls due.  However, the net level annual premium shall not exceed the net level annual premium on the nineteen-year premium whole life plan of insurance of the same renewal year equivalent level amount at an age one year higher than the age at issue of the policy; and

 

b.  A net one year term premium for the benefits provided for in the first policy year; and

 

(3)  The interest rates used in the present value calculations for any policy may not exceed the maximum valuation interest rate, determined with a guarantee duration equal to the length from issue to the mandatory expiration of the policy.

 

          (l)  “Universal life insurance policy” means any individual life insurance policy under the provisions of which separately identified interest credits (other than in connection with dividend accumulations, premium deposit funds, or other supplementary accounts) and mortality or expense charges are made to the policy.

 

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

PART Ins 3504  GENERAL CALCULATION REQUIREMENTS FOR BASIC RESERVES AND

PREMIUM DEFICIENCY RESERVES

 

          Ins 3504.01  Basic Reserves Calculation Requirements.

 

          (a)  At the election of the company for any one or more specified plans of life insurance, the minimum mortality standard for basic reserves may be calculated using the 1980 CSO valuation tables with select mortality factors (or any other valuation mortality table adopted by the NAIC after the 2017 effective date of this rule and promulgated by rule by the commissioner for this purpose).  If select mortality factors are elected, they may be:

 

(1)  The ten-year select mortality factors incorporated into the 1980 amendments to the NAIC Standard Valuation Law, available as referenced in Appendix B;

 

(2)  The select mortality factors in Appendix 1; or

 

(3)  Any other table of select mortality factors adopted by the NAIC after the 2017 effective date of this rule and promulgated by rule by the commissioner for the purpose of calculating basic reserves.

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

          Ins 3504.02  Deficiency Reserves Calculation Requirements.

 

          (a)  Deficiency reserves, if any, are calculated for each policy as the excess, if greater than zero, of the quantity A over the basic reserve.  The quantity A is obtained by recalculating the basic reserve for the policy using guaranteed gross premiums instead of net premiums when the guaranteed gross premiums are less than the corresponding net premiums.  At the election of the company for any one or more specified plans of insurance, the quantity A and the corresponding net premiums used in the determination of quantity A may be based upon the 1980 CSO valuation tables with select mortality factors (or any other valuation mortality table adopted by the NAIC after the 2017 effective date of this rule and promulgated by rule by the commissioner).  If selected mortality factors are elected, they may be:

 

(1)  The ten-year select mortality factors incorporated into the 1980 amendments to the NAIC Standard Valuation Law;

 

(2)  The select mortality factors in Appendix 1 of this rule;

 

(3)  For durations in the first segment, X percent of the select mortality factors in Appendix 1, subject to the following:

 

a.  X may vary by policy year, policy form, underwriting classification, issue age, or any other policy factor expected to affect mortality experience;

 

b.  X shall not be less than twenty percent (20%);

 

c.  X shall not decrease in any successive policy years;

 

d.  X is such that, when using the valuation interest rate used for basic reserves, Item 1. is greater than or equal to Item 2.:

 

1.  The actuarial present value of future death benefits, calculated using the mortality rates resulting from the application of X; and

 

2.  The actuarial present value of future death benefits calculated using anticipated mortality experience without recognition of mortality improvement beyond the valuation date;

 

e.  X is such that the mortality rates resulting from the application of X are at least as great as the anticipated mortality experience, without recognition of mortality improvement beyond the valuation date, in each of the first five (5) years after the valuation date;

 

f.  The appointed actuary shall increase X at any valuation date where it is necessary to continue to meet all the requirements of  Ins 3504.02(a)(3);

 

g.  The appointed actuary may decrease X at any valuation date as long as X does not decrease in any successive policy years and as long as it continues to meet all the requirements of Ins 3504.02(a)(3);

 

h.  The appointed actuary shall specifically take into account the adverse effect on expected mortality and lapsation of any anticipated or actual increase in gross premiums; and

 

i.  If X is less than 100 percent at any duration for any policy, the following requirements shall be met:

 

1. The appointed actuary shall annually prepare an actuarial opinion and memorandum for the company in conformance with the requirements of Ins 2400, Actuarial Opinion and Memorandum;

 

2.  The appointed actuary shall disclose, in the Regulatory Asset-Adequacy Issues Summary, the impact of the insufficiency of assets to support the payment of benefits and expenses and the establishment of statutory reserves during one or more interim periods; and

 

3.  The appointed actuary shall annually opine for all policies subject to this rule as to whether the mortality rates resulting from the application of X meet the requirements of Ins 3504.02(a)(3).  This opinion shall be supported by an actuarial report, subject to appropriate Actuarial Standards of Practice promulgated by the Actuarial Standards Board of American Academy of Actuaries and available as referenced in Appendix B.  The X factors shall reflect anticipated future mortality, without recognition of mortality improvement beyond the valuation date, taking into account relevant emerging experience; and

 

(4)  Any other table of select mortality factors adopted by the NAIC after the 2017 effective date of this rule and promulgated by rule by the commissioner for the purpose of calculating deficiency reserves.

 

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

          Ins 3504.03  Other Calculation Requirements.

 

          (a)  This subsection applies to both basic reserves and deficiency reserves.  Any set of select mortality factors may be used only for the first segment.  However, if the first segment is less than ten (10) years, the appropriate ten-year select mortality factors incorporated into the 1980 amendments to the NAIC Standard Valuation Law may be used thereafter through the tenth policy year from the date of issue.

 

          (b)  In determining basic reserves or deficiency reserves, guaranteed gross premiums without policy fees may be used where the calculation involves the guaranteed gross premium but only if the policy fee is a level dollar amount after the first policy year.  In determining deficiency reserves, policy fees may be included in guaranteed gross premiums, even if not included in the actual calculation of basic reserves.

 

          (c)  Reserves for policies that have changes to guaranteed gross premiums, guaranteed benefits, guaranteed charges, or guaranteed credits that are unilaterally made by the insurer after issue and that are effective for more than one year after the date of the change shall be the greatest of the following:

 

(1)  Reserves calculated ignoring the guarantee;

 

(2)  Reserves assuming the guarantee was made at issue; and

 

(3)  Reserves assuming that the policy was issued on the date of the guarantee.

 

          (d)  The commissioner may require that the company document the extent of the adequacy of reserves for specified blocks, including but not limited to policies issued prior to the 2017 effective date of this rule.  This documentation may include a demonstration of the extent to which aggregation with other non-specified blocks of business is relied upon in the formation of the appointed actuary opinion pursuant to and consistent with the requirements of  Ins 2400, Actuarial Opinion and Memorandum.

 

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

PART Ins 3505  CALCULATION OF MINIMUM VALUATION STANDARD FOR POLICIES WITH

GUARANTEED NONLEVEL GROSS PREMIUMS OR GUARANTEED

NONLEVEL BENEFITS (OTHER THAN UNIVERSAL LIFE POLICIES)

 

          Ins 3505.01  Calculation of Basic Reserves.

 

          (a)  Basic reserves shall be calculated as the greater of the segmented reserves and the unitary reserves.  Both the segmented reserves and the unitary reserves for any policy shall use the same valuation mortality table and selection factors.  At the option of the insurer, in calculating segmented reserves and net premiums, either of the adjustments described in paragraph (1) or (2) below may be made:

 

(1)  Treat the unitary reserve, if greater than zero, applicable at the end of each segment as a pure endowment and subtract the unitary reserve, if greater than zero, applicable at the beginning of each segment from the present value of guaranteed life insurance and endowment benefits for each segment; or

 

(2)  Treat the guaranteed cash surrender value, if greater than zero, applicable at the end of each segment as a pure endowment and subtract the guaranteed cash surrender value, if greater than zero, applicable at the beginning of each segment from the present value of guaranteed life insurance and endowment benefits for each segment.

 

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

          Ins 3505.02  Calculation of Deficiency Reserves.

 

          (a)  The deficiency reserve at any duration shall be calculated:

 

(1)  On a unitary basis if the corresponding basic reserve determined by Ins 3505.01 is unitary;

 

(2)  On a segmented basis if the corresponding basic reserve determined by Ins 3505.01 is segmented; or

 

(3)  On the segmented basis if the corresponding basic reserve determined by Ins 3506.01 is equal to both the segmented reserve and the unitary reserve.

 

          (b)  This subsection shall apply to any policy for which the guaranteed gross premium at any duration is less than the corresponding net premium calculated by the method used in determining the basic reserves, but using the minimum valuation standards of mortality (specified in Ins 3504.01) and rate of interest.

 

          (c)  Deficiency reserves, if any, shall be calculated for each policy as the excess, if greater than zero, for the current and all remaining periods, of the quantity A over the basic reserve, where A is obtained as indicated in Ins 3504.01.

 

          (d)  For deficiency reserves determined on a segmented basis, the quantity A is determined using segment lengths equal to those determined for segmented basic reserves.

 

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

          Ins 3505.03  Minimum Value.  Basic reserves may not be less than the tabular cost of insurance for the balance of the policy year, if mean reserves are used.  Basic reserves may not be less than the tabular cost of insurance for the balance of the current modal period or to the paid-to-date, if later, but not beyond the next policy anniversary, if mid-terminal reserves are used.  The tabular cost of insurance shall use the same valuation mortality table and interest rates as that used for the calculation of the segmented reserves.  However, if select mortality factors are used, they shall be the ten-year select factors incorporated into the 1980 amendments of the NAIC Standard Valuation Law.  In no case may total reserves (including basic reserves, deficiency reserves and any reserves held for supplemental benefits that would expire upon contract termination) be less than the amount that the policyowner would receive (including the cash surrender value of the supplemental benefits, if any, referred to above), exclusive of any deduction for policy loans, upon termination of the policy.

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

          Ins 3505.04  Unusual Pattern of Guaranteed Cash Surrender Values.

 

          (a)  For any policy with an unusual pattern of guaranteed cash surrender values, the reserves actually held prior to the first unusual guaranteed cash surrender value shall not be less than the reserves calculated by treating the first unusual guaranteed cash surrender value as a pure endowment and treating the policy as an n year policy providing term insurance plus a pure endowment equal to the unusual cash surrender value, where n is the number of years from the date of issue to the date the unusual cash surrender value is scheduled.

 

          (b)  The reserves actually held subsequent to any unusual guaranteed cash surrender value shall not be less than the reserves calculated by treating the policy as an n year policy providing term insurance plus a pure endowment equal to the next unusual guaranteed cash surrender value, and treating any unusual guaranteed cash surrender value at the end of the prior segment as a net single premium, where

 

(1)  n is the number of years from the date of the last unusual guaranteed cash surrender value prior to the valuation date to the earlier of:

 

a.  The date of the next unusual guaranteed cash surrender value, if any, that is scheduled after the valuation date; or

 

b.  The mandatory expiration date of the policy; and

 

(2)  The net premium for a given year during the n year period is equal to the product of the net to gross ratio and the respective gross premium; and

 

(3)  The net to gross ratio is equal to Item a. divided by Item b. as follows:

 

a.  The present value, at the beginning of the n year period, of death benefits payable during the n year period plus the present value, at the beginning of the n year period, of the next unusual guaranteed cash surrender value, if any, minus the amount of the least unusual guaranteed cash surrender value, if any, scheduled at the beginning of the n year period; and

 

b.  The present value, at the beginning of the n year period, of the scheduled gross premiums payable during the n year period.

 

          (c)  For purposes of this subsection, a policy is considered to have an unusual pattern of guaranteed cash surrender values if any future guaranteed cash surrender value exceeds the prior year’s guaranteed cash surrender value by more than the sum of:

 

(1)  One hundred ten percent (110%) of the scheduled gross premium for that year;

 

(2)  One hundred ten percent (110%) of one year’s accrued interest on the sum of the prior year’s guaranteed cash surrender value and the scheduled gross premium using the nonforfeiture interest rate used for calculating policy guaranteed cash surrender values; and

 

(3)  Five percent (5%) of the first policy year surrender charge, if any.

 

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

          Ins 3505.05  Optional Exemption for Yearly Renewable Term Reinsurance.

 

          (a)  At the option of the company, the following approach for reserves on YRT reinsurance may be used:

 

(1)  Calculate the valuation net premium for each future policy year as the tabular cost of insurance for that future year;

 

(2)  Basic reserves shall never be less than the tabular cost of insurance for the appropriate period, as defined in Ins 3505.03;

 

(3)  Deficiency reserves:

 

a.  For each policy year, calculate the excess, if greater than zero, of the valuation net premium over the respective maximum guaranteed gross premium; and

 

b.  Deficiency reserves shall never be less than the sum of the present values, at the date of valuation, of the excesses determined in accordance with subparagraph a. above;

 

(4)  For purposes of this subsection, the calculations use the maximum valuation interest rate and the 1980 CSO mortality tables with or without ten-year select mortality factors, or any other table adopted after the 2017 effective date of this rule by the NAIC and promulgated by rule by the commissioner for this purpose;

 

(5)  A reinsurance agreement shall be considered YRT reinsurance for purposes of this subsection if only the mortality risk is reinsured; and

 

(6)  If the assuming company chooses this optional exemption, the ceding company’s reinsurance reserve credit shall be limited to the amount of reserve held by the assuming company for the affected policies.

 

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

          Ins 3505.06  Optional Exemption for Attained-Age-Based Yearly Renewable Term Life Insurance Policies.

 

          (a)  At the option of the company, the following approach for reserves for attained-age-based YRT life insurance policies may be used:

 

(1)  Calculate the valuation net premium for each future policy year as the tabular cost of insurance for that future year;

 

(2)  Basic reserves shall never be less than the tabular cost of insurance for the appropriate period, as defined in Ins 3505.03;

 

(3)  Deficiency reserves:

 

a.  For each policy year, calculate the excess, if greater than zero, of the valuation net premium over the respective maximum guaranteed gross premium; and

 

b.  Deficiency reserves shall never be less than the sum of the present values, at the date of valuation, of the excesses determined in accordance with subparagraph a. above;

 

(4)  For purposes of this subsection, the calculations use the maximum valuation interest rate and the 1980 CSO valuation tables with or without ten-year select mortality factors, or any other table adopted after the 2017 effective date of this rule by the NAIC and promulgated by rule by the commissioner for this purpose;

 

(5)  A policy shall be considered an attained-age-based YRT life insurance policy for purposes of this subsection if:

 

a.  The premium rates (on both the initial current premium scale and the guaranteed maximum premium scale) are based upon the attained age of the insured such that the rate for any given policy at a given attained age of the insured is independent of the year the policy was issued; and

 

b.  The premium rates (on both the initial current premium scale and the guaranteed maximum premium scale) are the same as the premium rates for policies covering all insureds of the same sex, risk class, plan of insurance and attained age;

 

(6)  For policies that become attained-age-based YRT policies after an initial period of coverage, the approach of this subsection may be used after the initial period if:

 

a.  The initial period is constant for all insureds of the same sex, risk class and plan of insurance; or

 

b.  The initial period runs to a common attained age for all insureds of the same sex, risk class and plan of insurance; and

 

c.  After the initial period of coverage, the policy meets the conditions of subparagraph (5) above; and

 

(7)  If this election is made, this approach shall be applied in determining reserves for all attained-age-based YRT life insurance policies issued on or after the 2017 effective date of this rule.

 

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

          Ins 3505.07  Exemption from Unitary Reserves for Certain n-Year Renewable Term Life Insurance Policies.

 

          (a)  Unitary basic reserves and unitary deficiency reserves need not be calculated for a policy if the following conditions are met:

 

(1)  The policy consists of a series of n-year periods, including the first period and all renewal periods, where n is the same for each period, except that for the final renewal period, n may be truncated or extended to reach the expiry age, provided that this final renewal period is less than 10 years and less than twice the size of the earlier n-year periods, and for each period, the premium rates on both the initial current premium scale and the guaranteed maximum premium scale are level;

 

(2)  The guaranteed gross premiums in all n-year periods are not less than the corresponding net premiums based upon the 1980 CSO Table with or without the ten-year select mortality factors; and

 

(3)  There are no cash surrender values in any policy year.

 

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

          Ins 3505.08  Exemption from Unitary Reserves for Certain Juvenile Policies.

 

          (a)  Unitary basic reserves and unitary deficiency reserves need not be calculated for a policy if the following conditions are met, based upon the initial current premium scale at issue:

 

(1)  At issue, the insured is age twenty-four (24) or younger;

 

(2)  Until the insured reaches the end of the juvenile period, which shall occur at or before age twenty-five (25), the gross premiums and death benefits are level, and there are no cash surrender values; and

 

(3)  After the end of the juvenile period, gross premiums are level for the remainder of the premium paying period, and death benefits are level for the remainder of the life of the policy.

 

Source.  #7419, eff 7-1-01; ss by #9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

PART Ins 3506  CALCULATION OF MINIMUM VALUATION STANDARD FOR FLEXIBLE PREMIUM AND FIXED PREMIUM UNIVERSAL LIFE INSURANCE POLICIES THAT CONTAIN PROVISIONS RESULTING IN THE ABILITY OF A POLICYOWNER TO KEEP A POLICY IN FORCE OVER A SECONDARY GUARANTEE PERIOD

 

          Ins 3506.01  General Provisions.

 

          (a)  Policies with a secondary guarantee include:

 

(1)  A policy with a guarantee that the policy will remain in force at the original schedule of benefits, subject only to the payment of specified premiums;

 

(2)  A policy in which the minimum premium at any duration is less than the corresponding one year valuation premium, calculated using the maximum valuation interest rate and the 1980 CSO valuation tables with or without ten-year select mortality factors, or any other table adopted after the 2017 effective date of this rule by the NAIC and promulgated by rule by the commissioner for this purpose; or

 

(3)  A policy with any combination of subparagraphs (1) and (2) above.

 

          (b)  A secondary guarantee period is the period for which the policy is guaranteed to remain in force subject only to a secondary guarantee.  When a policy contains more than one secondary guarantee, the minimum reserve shall be the greatest of the respective minimum reserves at that valuation date of each unexpired secondary guarantee, ignoring all other secondary guarantees.  Secondary guarantees that are unilaterally changed by the insurer after issue shall be considered to have been made at issue.  Reserves described in Ins 3506.02 and Ins 3506.03 below shall be recalculated from issue to reflect these changes.

 

          (c)  Specified premiums mean the premiums specified in the policy, the payment of which guarantees that the policy will remain in force at the original schedule of benefits, but which otherwise would be insufficient to keep the policy in force in the absence of the guarantee if maximum mortality and expense charges and minimum interest credits were made and any applicable surrender charges were assessed.

 

          (d)  For purposes of this section, the minimum premium for any policy year is the premium that, when paid into a policy with a zero account value at the beginning of the policy year, produces a zero account value at the end of the policy year.  The minimum premium calculation shall use the policy cost factors (including mortality charges, loads and expense charges) and the interest crediting rate, which are all guaranteed at issue.

 

          (e)  The one-year valuation premium means the net one-year premium based upon the original schedule of benefits for a given policy year.  The one-year valuation premiums for all policy years are calculated at issue.  The select mortality factors defined in Ins 3504.02(a)(2), Ins 3504.02(a)(3), and Ins 3504.02(a)(4) may not be used to calculate the one-year valuation premiums.

 

          (f)  The one-year valuation premium should reflect the frequency of fund processing, as well as the distribution of deaths assumption employed in the calculation of the monthly mortality charges to the fund.

 

Source.  #7419, eff 7-1-01; ss by # 9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

          Ins 3506.02  Basic Reserves for the Secondary Guarantees.  Basic reserves for the secondary guarantees shall be the segmented reserves for the secondary guarantee period.  In calculating the segments and the segmented reserves, the gross premiums shall be set equal to the specified premiums, if any, or otherwise to be minimum premiums, that keep the policy in force and the segments will be determined according to the contract segmentation method as defined in Ins 3503.01(b).

 

Source.  #7419, eff 7-1-01; ss by # 9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

          Ins 3506.03  Deficiency Reserves for the Secondary Guarantees.  Deficiency reserves, if any, for the secondary guarantees shall be calculated for the secondary guarantee period in the same manner as described in Ins 3505.02 with gross premiums set equal to the specified premiums, if any, or otherwise to the minimum premiums that keep the policy in force.

 

Source.  #7419, eff 7-1-01; ss by # 9516, eff 7-25-09; ss by #12219, eff 7-25-17

 

          Ins 3506.04  Minimum Reserves. 

 

          (a)  The minimum reserves during the secondary guarantee period are the greater of:

 

(1)  The basic reserves for the secondary guarantee plus the deficiency reserve, if any, for the secondary guarantees; or

 

(2)  The minimum reserves required by other rules or rules governing universal life plans.

 

Source.  #7419, eff 7-1-01; ss by # 9516, eff 7-25-09; ss by #12219, eff 7-25-17


APPENDIX 1

 

 

SELECT MORTALITY FACTORS

 

 

This appendix contains tables of select mortality factors that are the bases to which the respective percentage of Ins 3504.01 (a) (2), Ins 3504.02 (a) (2), and Ins 3504.02 (a) (3) are applied.

 

The six tables of select mortality factors contained herein include:

 

(1)  male aggregate,

 

(2)  male nonsmoker,

 

(3)  male smoker,

 

(4)  female aggregate,

 

(5)  female nonsmoker, and

 

(6)  female smoker.

 

These tables apply to both age last birthday and age nearest birthday mortality tables.

 

For sex-blended mortality tables, compute select mortality factors in the same proportion as the underlying mortality.  For example, for the 1980 CSO-B Table, the calculated select mortality factors are eighty percent (80%) of the appropriate male table in this Appendix, plus twenty percent (20%) of the appropriate female table in this Appendix.

 


Appendix

 

SELECT MORTALITY FACTORS

Male, Aggregate

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

0-15

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

16

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

17

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

18

96

98

98

99

99

100

100

90

92

92

92

92

93

93

96

97

98

98

99

100

19

83

84

84

87

87

87

79

79

79

81

81

82

82

82

85

88

91

94

97

100

20

69

71

71

74

74

69

69

67

69

70

71

71

71

71

74

79

84

90

95

100

21

66

68

69

71

66

66

67

66

67

70

70

70

70

71

71

77

83

88

94

100

22

65

66

66

63

63

64

64

64

65

68

68

68

68

69

71

77

83

88

94

100

23

62

63

59

60

62

62

63

63

64

65

65

67

67

69

70

76

82

88

94

100

24

60

56

56

59

59

60

61

61

61

64

64

64

66

67

70

76

82

88

94

100

25

52

53

55

56

58

58

60

60

60

63

62

63

64

67

69

75

81

88

94

100

26

51

52

55

56

58

58

57

61

61

62

63

64

66

69

66

73

80

86

93

100

27

51

52

55

57

58

60

61

61

60

63

63

64

67

66

67

74

80

86

93

100

28

49

51

56

58

60

60

61

62

62

63

64

66

65

66

68

74

81

87

94

100

29

49

51

56

58

60

61

62

62

62

64

64

62

66

67

70

76

82

88

94

100

30

49

50

56

58

60

60

62

63

63

64

62

63

67

68

71

77

83

88

94

100

31

47

50

56

58

60

62

63

64

64

62

63

66

68

70

72

78

83

89

94

100

32

46

49

56

59

60

62

63

66

62

63

66

67

70

72

73

78

84

89

95

100

33

43

49

56

59

62

63

64

62

65

66

67

70

72

73

75

80

85

90

95

100

34

42

47

56

60

62

63

61

63

66

67

70

71

73

75

76

81

86

90

95

100

35

40

47

56

60

63

61

62

65

67

68

71

73

74

76

76

81

86

90

95

100

36

38

42

56

60

59

61

63

65

67

68

70

72

74

76

77

82

86

91

95

100

37

38

45

56

57

61

62

63

65

67

68

70

72

74

76

76

81

86

90

95

100

38

37

44

53

58

61

62

65

66

67

69

69

73

75

76

77

82

86

91

95

100

39

37

41

53

58

62

63

65

66

67

68

69

72

74

76

76

81

86

90

95

100

40

34

40

53

58

62

63

65

65

66

68

68

71

75

76

77

82

86

91

95

100

 


Male, Aggregate

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

41

34

41

53

58

62

63

65

64

64

66

68

70

74

76

77

82

86

91

95

100

42

34

43

53

58

61

62

63

63

63

64

66

69

72

75

77

82

86

91

85

100

43

34

43

54

59

60

61

63

62

62

64

66

67

72

74

77

82

86

91

95

100

44

34

44

54

58

59

60

61

60

61

62

64

67

71

74

77

82

86

91

95

100

45

34

45

53

58

59

60

60

60

59

60

63

66

71

74

77

82

86

91

95

100

46

31

43

52

56

57

58

59

59

59

60

63

67

71

74

75

80

85

90

95

100

47

32

42

50

53

55

56

57

58

59

60

65

68

71

74

75

80

85

90

95

100

48

32

41

47

52

54

56

57

57

57

61

65

68

72

73

74

79

84

90

95

100

49

30

40

46

49

52

54

55

56

57

61

66

69

72

73

74

79

84

90

95

100

50

30

38

44

47

51

53

54

56

57

61

66

71

72

73

75

80

85

90

95

100

51

28

37

42

46

49

53

54

56

57

61

66

71

72

73

75

80

85

90

95

100

52

28

35

41

45

49

51

54

56

57

61

66

71

72

74

75

80

85

90

100

100

53

27

35

39

44

48

51

53

55

57

61

67

71

74

75

76

81

86

100

100

100

54

27

33

38

33

48

50

53

55

57

61

67

72

74

75

76

81

100

100

100

100

55

25

32

37

43

47

59

53

55

57

61

68

72

74

75

78

100

100

100

100

100

56

25

32

37

43

47

49

51

54

56

61

67

70

73

74

100

100

100

100

100

100

57

24

31

38

43

47

49

51

54

56

59

66

69

72

100

100

100

100

100

100

100

58

24

31

38

43

48

48

50

53

56

59

64

67

100

100

100

100

100

100

100

100

59

23

30

39

43

48

48

51

53

55

58

63

100

100

100

100

100

100

100

100

100

60

23

30

39

43

48

47

50

52

53

57

100

100

100

100

100

100

100

100

100

100

61

23

30

39

43

49

49

50

52

53

75

100

100

100

100

100

100

100

100

100

100

62

23

30

39

44

49

49

51

52

75

75

100

100

100

100

100

100

100

100

100

100

63

22

30

39

45

50

50

52

75

75

75

100

100

100

100

100

100

100

100

100

100

64

22

30

39

45

50

51

75

75

75

75

100

100

100

100

100

100

100

100

100

100

65

22

30

39

45

50

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

66

22

30

39

45

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

67

22

30

39

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

68

23

32

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

69

23

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

70

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

 

 


Male, Aggregate

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

71

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

72

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

73

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

74

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

75

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

76

48

52

55

60

60

65

70

70

70

100

100

100

100

100

100

100

100

100

100

100

77

48

52

55

60

60

65

70

70

100

100

100

100

100

100

100

100

100

100

100

100

78

48

52

55

60

60

65

70

100

100

100

100

100

100

100

100

100

100

100

100

100

79

48

52

55

60

60

65

100

100

100

100

100

100

100

100

100

100

100

100

100

100

80

48

52

55

60

60

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

81

48

52

55

60

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

82

48

52

55

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

83

48

52

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

84

48

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

85+

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

 


 

Male, Non-Smoker

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

0-15

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

16

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

17

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

18

93

95

96

98

99

100

100

90

92

92

92

92

95

95

96

97

98

98

99

100

19

80

81

83

86

87

87

79

79

79

81

81

82

83

83

86

89

92

94

97

100

20

65

68

69

72

74

69

69

67

69

70

71

71

72

72

75

80

85

90

95

100

21

63

66

68

71

66

66

67

66

67

70

70

70

71

71

73

78

84

89

95

100

22

62

65

66

62

63

64

64

64

67

68

68

68

70

70

73

78

84

89

95

100

23

60

62

58

60

62

62

63

63

64

67

68

68

67

69

71

77

83

88

94

100

24

59

55

56

58

59

60

61

61

63

65

67

66

66

69

71

77

83

88

94

100

25

52

53

55

56

58

58

60

60

61

64

64

64

64

67

70

76

82

88

94

100

26

51

53

55

56

58

60

61

61

61

63

64

64

66

69

67

74

80

87

93

100

27

51

52

55

58

69

69

61

61

62

63

64

66

67

66

67

74

80

87

93

100

28

49

52

57

58

60

61

63

62

62

64

66

66

63

66

68

74

81

87

94

100

29

49

51

57

60

61

61

62

62

63

64

66

63

65

67

68

74

81

87

94

100

30

49

51

57

60

61

62

63

63

63

64

62

63

66

68

70

76

82

88

94

100

31

47

50

57

60

60

62

63

64

64

62

63

65

67

70

71

77

83

88

94

100

32

46

50

57

60

62

63

64

64

62

63

65

66

68

71

72

78

83

89

94

100

33

45

49

56

60

52

63

64

62

63

65

66

68

71

73

74

79

84

90

95

100

34

43

48

56

62

63

64

62

62

65

66

67

70

72

74

74

79

84

90

95

100

35

41

47

56

62

63

61

62

63

66

67

68

70

72

74

75

80

85

90

95

100

36

40

47

56

62

59

61

62

63

66

67

68

70

72

74

75

80

85

90

95

100

37

38

45

56

58

59

61

62

63

66

67

67

69

71

73

74

79

84

90

95

100

38

38

45

53

58

61

62

63

65

65

67

68

70

72

74

73

78

84

89

95

100

39

37

41

53

58

61

62

63

64

65

67

68

70

71

73

73

78

84

89

95

100

40

34

41

53

58

61

62

63

64

64

66

67

69

71

73

72

78

83

89

94

100

 


Male, Non-Smoker

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

41

34

41

53

58

61

61

62

62

63

65

65

67

69

71

71

77

83

88

94

100

42

34

43

53

58

60

61

62

61

61

63

64

66

67

69

71

77

83

88

94

100

43

32

43

53

58

60

61

60

60

60

60

62

64

66

68

69

75

81

88

94

100

44

32

44

52

57

59

60

60

59

59

58

60

62

65

67

69

75

81

88

94

100

45

32

44

52

57

59

60

59

57

57

57

59

61

63

66

68

74

81

87

94

100

46

32

42

50

54

56

57

57

56

55

56

59

61

63

65

67

74

80

87

93

100

47

30

40

48

52

54

55

55

54

54

55

59

61

62

63

66

73

80

86

93

100

48

30

40

46

49

51

52

53

53

54

55

57

61

62

63

63

70

78

85

93

100

49

29

39

43

48

50

51

50

51

53

54

57

61

61

62

62

70

77

85

92

100

50

29

37

42

45

47

48

49

50

51

54

57

61

61

61

61

69

77

84

92

100

51

27

35

40

43

45

47

48

50

51

53

57

60

61

61

62

70

77

85

92

100

52

27

34

39

42

44

45

48

49

50

53

56

60

60

62

62

70

77

85

100

100

53

25

31

37

41

44

45

47

49

50

51

56

59

61

61

62

70

77

100

100

100

54

25

30

36

39

43

44

47

48

49

51

55

59

59

61

62

70

100

100

100

100

55

24

29

35

38

42

43

45

48

49

50

56

58

59

61

62

100

100

100

100

100

56

23

29

35

38

42

42

44

47

48

50

55

57

58

59

100

100

100

100

100

100

57

23

28

35

38

42

42

43

45

47

49

53

55

56

100

100

100

100

100

100

100

58

22

28

33

37

41

41

43

45

45

47

51

53

100

100

100

100

100

100

100

100

59

22

26

33

37

41

41

42

44

44

46

50

100

100

100

100

100

100

100

100

100

60

20

26

33

37

41

40

41

42

42

45

100

100

100

100

100

100

100

100

100

100

61

20

26

33

37

41

40

41

42

42

75

100

100

100

100

100

100

100

100

100

100

62

19

25

32

38

40

40

41

42

75

75

100

100

100

100

100

100

100

100

100

100

63

19

25

33

36

40

40

41

75

75

75

100

100

100

100

100

100

100

100

100

100

64

18

24

32

36

39

40

75

75

75

75

100

100

100

100

100

100

100

100

100

100

65

18

24

32

36

39

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

66

18

24

32

36

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

67

18

24

32

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

68

18

24

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

69

18

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

70

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

 


Male, Non-Smoker

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

71

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

72

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

73

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

74

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

75

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

76

48

52

55

60

60

65

70

70

70

100

100

100

100

100

100

100

100

100

100

100

77

48

52

55

60

60

65

70

70

100

100

100

100

100

100

100

100

100

100

100

100

78

48

52

55

60

60

65

70

100

100

100

100

100

100

100

100

100

100

100

100

100

79

48

52

55

60

60

65

100

100

100

100

100

100

100

100

100

100

100

100

100

100

80

48

52

55

60

60

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

81

48

52

55

60

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

82

48

52

55

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

83

48

52

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

84

48

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

85+

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

 

 


 

Male, Smoker

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

0-15

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

16

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

17

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

18

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

19

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

20

98

100

100

100

100

100

100

99

99

99

100

99

99

99

100

100

100

100

100

100

21

95

98

99

100

95

96

96

95

96

97

97

96

96

96

96

97

98

98

99

100

22

92

95

96

90

90

93

93

92

93

95

95

93

93

92

93

94

96

97

99

100

23

90

92

85

88

88

89

89

89

90

90

90

90

89

90

92

94

95

97

98

100

24

87

81

82

85

84

86

88

86

86

86

88

86

86

88

89

91

93

96

98

100

25

77

78

79

82

81

83

83

82

83

85

84

84

84

85

86

89

92

94

97

100

26

75

77

79

82

82

83

83

82

83

84

84

84

84

85

81

85

89

92

96

100

27

73

75

78

82

82

83

83

82

82

82

82

84

84

80

81

85

89

92

96

100

28

71

73

79

82

81

82

83

81

81

82

82

82

80

80

81

85

89

92

96

100

29

69

72

78

81

81

82

82

81

81

81

81

77

80

80

81

85

89

92

96

100

30

68

71

78

81

81

81

82

81

81

81

76

77

80

80

81

85

89

92

96

100

31

65

70

77

81

79

81

82

81

81

76

77

79

81

81

83

86

90

93

97

100

32

63

67

77

78

79

81

81

81

76

77

77

80

83

83

85

88

91

94

97

100

33

60

65

74

78

79

79

81

76

77

77

79

80

83

85

85

88

91

94

97

100

34

57

62

74

77

79

79

75

76

77

79

79

81

83

85

87

90

92

95

97

100

35

53

60

73

77

79

75

75

76

77

79

80

82

84

86

88

90

93

95

98

100

36

52

59

71

75

74

75

75

76

77

79

79

81

83

85

87

90

92

95

97

100

37

49

58

70

71

74

74

75

76

77

78

79

81

84

86

86

89

92

94

97

100

38

48

55

66

70

72

74

74

75

76

78

79

81

83

85

87

90

92

95

97

100

39

45

50

65

70

72

72

74

74

75

77

79

81

84

86

86

89

92

94

97

100

40

41

49

63

68

71

72

73

74

74

76

78

80

83

85

86

89

92

94

97

100

 


Male, Smoker

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

41

40

49

63

68

71

72

72

72

73

75

76

78

81

84

85

88

91

94

97

100

42

40

49

62

68

60

71

71

71

71

73

75

76

81

83

85

88

91

94

97

100

43

39

50

62

67

69

69

70

70

70

71

73

76

79

83

85

88

91

94

97

100

44

39

50

60

66

68

69

68

69

69

69

71

74

79

81

85

88

91

94

97

100

45

37

50

60

66

68

68

68

67

67

67

69

73

78

81

85

88

91

94

97

100

46

37

48

58

63

65

67

66

66

66

67

71

74

78

81

84

87

90

94

97

100

47

36

47

55

61

63

64

64

64

65

67

71

75

79

81

84

87

90

94

97

100

48

35

46

53

58

60

62

63

63

65

67

72

75

79

81

83

86

90

93

97

100

49

34

45

51

56

58

59

61

62

63

67

72

77

80

81

83

86

90

93

97

100

50

34

43

49

53

55

57

60

61

63

67

73

78

80

81

81

85

90

94

97

100

51

32

42

47

52

55

57

60

61

63

67

73

78

80

83

84

87

90

94

97

100

52

32

40

46

50

54

56

60

61

63

67

73

78

81

84

85

88

91

94

100

100

53

30

37

44

49

54

56

59

61

65

67

74

79

83

85

87

90

92

100

100

100

54

30

36

43

48

53

55

59

61

65

67

74

80

84

85

89

91

100

100

100

100

55

29

35

42

47

53

55

59

61

65

67

75

80

84

86

90

100

100

100

100

100

56

28

35

42

47

53

55

57

60

63

68

74

79

83

85

100

100

100

100

100

100

57

28

35

42

47

53

54

57

60

64

67

74

78

81

100

100

100

100

100

100

100

58

26

33

43

48

54

54

56

59

63

67

73

78

100

100

100

100

100

100

100

100

59

26

33

43

48

54

53

57

59

63

66

73

100

100

100

100

100

100

100

100

100

60

25

33

43

48

54

53

56

58

62

66

100

100

100

100

100

100

100

100

100

100

61

25

33

43

49

55

55

57

59

63

75

100

100

100

100

100

100

100

100

100

100

62

25

33

43

50

56

56

58

61

75

75

100

100

100

100

100

100

100

100

100

100

63

24

33

45

51

56

56

59

75

75

75

100

100

100

100

100

100

100

100

100

100

64

24

34

45

51

57

57

75

75

75

75

100

100

100

100

100

100

100

100

100

100

65

24

34

45

52

57

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

66

24

35

45

53

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

67

25

35

45

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

68

25

36

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

69

27

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

70

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

 


Male, Smoker

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

71

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

72

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

73

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

74

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

75

48

52

55

60

60

65

70

70

70

70

100

100

100

100

100

100

100

100

100

100

76

48

52

55

60

60

65

70

70

70

100

100

100

100

100

100

100

100

100

100

100

77

48

52

55

60

60

65

70

70

100

100

100

100

100

100

100

100

100

100

100

100

78

48

52

55

60

60

65

70

100

100

100

100

100

100

100

100

100

100

100

100

100

79

48

52

55

60

60

65

100

100

100

100

100

100

100

100

100

100

100

100

100

100

80

48

52

55

60

60

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

81

48

52

55

60

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

82

48

52

55

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

83

48

52

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

84

48

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

85+

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

 

 


Female, Aggregate

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

0-15

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

16

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

17

99

100

100

100

100

100

100

100

93

95

96

97

100

100

100

100

100

100

100

100

18

83

83

84

84

84

84

86

78

78

79

82

84

85

88

88

90

93

95

98

100

19

65

66

68

68

68

68

63

63

64

66

69

71

72

74

75

80

85

90

95

100

20

48

50

51

51

51

47

48

48

49

51

56

57

58

61

63

70

78

85

93

100

21

47

48

50

51

47

47

48

49

51

53

57

60

61

64

64

71

78

86

93

100

22

44

47

48

45

47

47

48

49

53

54

60

61

63

64

66

73

80

86

93

100

23

42

45

44

45

47

47

49

51

53

54

61

64

64

67

69

75

81

88

94

100

24

39

40

42

44

47

47

50

51

54

56

64

64

66

69

70

76

82

88

94

100

25

34

38

41

44

47

47

50

53

56

57

64

67

69

71

73

78

84

89

95

100

26

34

38

41

45

49

49

51

56

58

59

66

69

70

73

70

76

82

88

94

100

27

34

38

41

47

50

51

54

57

59

60

69

70

73

70

71

77

83

88

94

100

28

34

37

43

47

53

53

56

59

62

63

70

73

70

72

74

79

84

90

95

100

29

34

38

43

49

54

56

58

60

63

64

73

70

72

74

75

80

85

90

95

100

30

35

38

43

50

56

56

59

63

66

67

70

71

74

75

76

81

86

90

95

100

31

35

38

43

51

56

58

60

64

67

65

71

72

74

75

76

81

86

90

95

100

32

35

39

45

51

56

59

63

66

65

66

72

72

75

76

76

81

86

90

95

100

33

36

39

44

52

58

62

64

65

66

67

72

74

75

76

76

81

86

90

95

100

34

36

40

45

52

58

63

63

66

67

68

74

74

76

76

76

81

86

90

95

100

35

36

40

45

53

59

61

65

67

68

70

75

74

75

76

75

80

85

90

95

100

36

36

40

45

53

55

62

65

67

68

70

74

74

74

75

75

80

85

90

95

100

37

36

41

47

52

57

62

65

67

68

69

72

72

73

75

74

79

84

90

95

100

38

34

41

44

52

57

63

66

68

69

70

72

71

72

74

75

80

85

90

95

100

39

34

40

45

53

58

63

66

68

69

69

70

70

70

73

74

79

84

90

95

100

40

32

40

45

53

58

65

65

67

68

69

70

69

70

73

73

78

84

89

95

100

 


Female, Aggregate

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

41

32

40

45

53

57

63

64

67

68

68

69

69

69

73

74

79

84

90

95

100

42

32

40

45

52

56

61

63

65

66

68

69

68

70

74

75

80

85

90

95

100

43

31

39

45

51

55

59

61

65

65

66

68

69

69

74

77

82

86

91

95

100

44

31

39

45

50

54

58

61

63

64

66

67

68

71

75

78

82

87

91

96

100

45

31

38

44

49

53

56

59

62

63

65

67

68

71

77

79

83

87

92

96

100

46

29

37

43

48

51

54

59

62

63

65

67

69

71

77

78

82

87

91

96

100

47

28

35

41

46

49

54

57

61

62

66

68

69

71

77

77

82

86

91

95

100

48

28

35

41

44

49

52

57

61

63

66

68

71

72

75

77

82

86

91

95

100

49

26

34

39

43

47

52

55

61

63

67

69

71

72

75

75

80

85

90

95

100

50

25

32

38

41

46

50

55

61

63

67

69

72

72

75

74

79

84

90

95

100

51

25

32

38

41

45

50

55

61

63

66

68

69

71

74

74

79

84

90

95

100

52

23

30

36

41

45

51

56

61

62

65

66

68

68

73

73

78

84

89

100

100

53

23

30

36

41

47

51

56

61

62

63

65

66

68

72

72

78

83

100

100

100

54

22

29

35

41

47

53

57

61

61

62

62

66

66

69

70

76

100

100

100

100

55

22

29

35

41

47

53

57

61

61

61

62

63

64

68

69

100

100

100

100

100

56

22

29

35

41

45

51

56

59

60

61

62

63

64

67

100

100

100

100

100

100

57

22

29

35

41

45

50

54

56

58

59

61

62

63

100

100

100

100

100

100

100

58

22

30

36

41

44

49

53

56

57

57

61

62

100

100

100

100

100

100

100

100

59

22

30

36

41

44

48

51

53

55

56

59

100

100

100

100

100

100

100

100

100

60

22

30

36

41

43

47

50

51

53

55

100

100

100

100

100

100

100

100

100

100

61

22

29

35

39

42

46

49

50

52

80

100

100

100

100

100

100

100

100

100

100

62

20

28

33

39

41

45

47

49

80

80

100

100

100

100

100

100

100

100

100

100

63

20

28

33

38

41

44

46

80

80

80

100

100

100

100

100

100

100

100

100

100

64

19

27

32

36

40

42

80

80

80

80

100

100

100

100

100

100

100

100

100

100

65

19

25

30

35

39

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

66

19

25

30

35

72

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

67

19

25

30

72

72

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

68

19

25

68

72

72

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

69

19

64

68

72

72

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

70

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

 


Female, Aggregate

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

71

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

72

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

73

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

74

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

75

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

76

60

60

64

68

68

72

75

75

80

100

100

100

100

100

100

100

100

100

100

100

77

60

60

64

68

68

72

75

75

100

100

100

100

100

100

100

100

100

100

100

100

78

60

60

64

68

68

72

75

75

100

100

100

100

100

100

100

100

100

100

100

100

79

60

60

64

68

68

72

100

100

100

100

100

100

100

100

100

100

100

100

100

100

80

60

60

64

68

68

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

81

60

60

64

68

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

82

60

60

64

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

83

60

60

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

84

60

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

85+

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

 

 

 

 


Female, Non-Smoker

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

0-15

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

16

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

17

96

98

98

98

98

99

99

99

92

92

93

95

95

97

99

99

99

100

100

100

18

78

80

80

80

80

81

81

74

75

75

78

79

82

83

85

88

91

94

97

100

19

60

62

63

63

63

65

59

59

60

60

64

67

67

70

72

78

83

89

94

100

20

42

44

45

45

45

42

42

42

45

45

50

51

53

56

58

66

75

83

92

100

21

41

42

44

45

41

42

52

44

47

47

51

53

54

57

59

67

75

84

92

100

22

39

41

44

41

41

42

44

45

49

49

54

56

57

58

60

68

76

84

92

100

23

38

41

38

40

41

42

44

46

49

50

56

57

58

60

62

70

77

85

92

100

24

36

36

38

40

41

42

46

47

50

51

58

59

60

62

63

70

78

85

93

100

25

32

34

37

40

41

43

46

49

51

53

59

60

62

63

64

71

78

86

93

100

26

32

34

37

41

43

45

47

50

53

53

60

62

63

64

62

70

77

85

92

100

27

32

34

38

43

46

47

49

51

53

55

62

63

64

62

62

70

77

85

92

100

28

30

34

39

43

47

49

51

53

56

58

63

63

61

62

63

70

78

85

93

100

29

30

35

40

45

50

51

62

66

68

59

64

61

62

63

63

70

78

85

93

100

30

31

35

40

46

51

52

53

56

59

60

62

62

63

65

65

72

79

86

93

100

31

31

35

40

46

51

53

55

58

60

58

62

62

63

65

65

72

79

86

93

100

32

32

35

40

45

51

53

56

59

57

58

62

63

63

65

64

71

78

86

93

100

33

32

36

41

47

52

55

58

55

58

59

63

63

65

65

65

72

79

86

93

100

34

33

36

41

47

52

55

55

57

58

59

63

65

64

65

64

71

78

86

93

100

35

33

36

41

47

52

53

57

58

59

61

63

64

64

64

64

71

78

86

93

100

36

33

36

41

47

49

53

57

58

59

61

63

64

63

64

63

70

78

85

93

100

37

32

36

41

44

49

53

57

58

59

60

62

62

61

62

63

70

78

85

93

100

38

32

37

39

45

50

54

57

58

60

60

61

61

61

62

61

69

77

84

92

100

39

30

35

39

45

50

54

57

58

60

59

60

60

59

60

61

69

77

84

92

100

40

28

35

39

45

50

54

56

57

59

59

60

59

59

59

60

68

76

84

92

100

 


Female, Non-Smoker

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

41

28

35

39

45

49

52

55

55

58

57

58

59

58

59

60

68

76

84

92

100

42

27

35

39

44

49

52

54

55

56

57

57

57

58

60

61

69

77

84

92

100

43

27

34

39

44

47

50

53

53

55

55

56

57

56

60

61

69

77

84

92

100

44

26

34

38

42

47

50

52

53

54

55

55

55

56

61

62

70

77

85

92

100

45

26

33

38

42

45

48

51

51

52

53

54

55

56

61

62

70

77

85

92

100

46

24

32

37

40

43

47

49

51

52

53

54

55

56

60

61

69

77

84

92

100

47

24

30

35

39

42

45

47

49

51

53

54

55

56

59

60

68

76

84

92

100

48

23

30

35

37

40

44

47

49

50

53

54

55

55

59

57

66

74

83

91

100

49

23

29

33

35

39

42

45

48

50

53

54

55

55

57

56

65

74

82

91

100

50

21

27

32

34

37

41

44

48

50

53

54

55

55

56

55

64

73

82

91

100

51

21

26

30

34

37

41

44

48

49

51

53

53

54

55

55

64

73

82

91

100

52

20

25

30

33

37

41

44

47

48

50

50

51

51

55

53

62

72

81

100

100

53

19

24

29

32

37

41

43

47

48

48

49

49

51

52

52

62

71

100

100

100

54

18

24

29

32

37`

41

43

45

47

47

47

49

49

51

51

61

100

100

100

100

55

18

23

28

32

37

41

43

45

45

45

46

46

47

50

50

100

100

100

100

100

56

18

23

28

32

36

39

42

44

44

45

46

46

46

49

100

100

100

100

100

100

57

18

23

28

31

35

38

41

42

344

44

45

45

46

100

100

100

100

100

100

100

58

17

23

26

31

35

36

38

41

41

42

45

45

100

100

100

100

100

100

100

100

59

17

23

26

30

33

35

38

39

40

41

44

100

100

100

100

100

100

100

100

100

60

17

23

26

30

32

34

36

38

39

40

100

100

100

100

100

100

100

100

100

100

61

17

22

25

29

32

33

35

36

38

80

100

100

100

100

100

100

100

100

100

100

62

16

22

25

28

30

32

34

35

80

80

100

100

100

100

100

100

100

100

100

100

63

16

20

24

28

30

32

34

80

80

80

100

100

100

100

100

100

100

100

100

100

64

14

21

24

27

29

30

80

80

80

80

100

100

100

100

100

100

100

100

100

100

65

15

19

23

25

28

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

66

15

19

23

25

72

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

67

15

19

22

72

72

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

68

13

18

68

72

72

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

69

13

64

68

72

72

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

70

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

 


Female, Non-Smoker

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

71

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

72

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

73

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

74

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

75

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

76

60

60

64

68

68

72

75

75

80

100

100

100

100

100

100

100

100

100

100

100

77

60

60

64

68

68

72

75

75

100

100

100

100

100

100

100

100

100

100

100

100

78

60

60

64

68

68

72

75

75

100

100

100

100

100

100

100

100

100

100

100

100

79

60

60

64

68

68

72

100

100

100

100

100

100

100

100

100

100

100

100

100

100

80

60

60

64

68

68

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

81

60

60

64

68

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

82

60

60

64

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

83

60

60

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

84

60

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

85+

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

 

 

 


Female, Smoker

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

0-15

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

16

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

17

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

18

99

100

100

100

100

100

100

95

96

97

100

100

100

100

100

100

100

100

100

100

19

87

89

92

92

92

92

84

84

86

86

92

93

95

96

99

99

99

100

100

100

20

74

77

80

80

80

73

73

73

75

77

83

83

86

88

90

92

94

96

98

100

21

71

74

78

78

71

71

73

74

77

79

85

86

88

89

90

92

94

96

98

100

22

68

71

75

70

71

71

73

74

78

79

88

90

89

89

92

94

95

97

98

100

23

65

69

67

70

70

70

73

77

79

81

89

90

90

92

92

94

95

97

98

100

24

62

60

64

69

70

70

74

77

79

81

92

90

92

93

93

94

96

97

99

100

25

53

58

63

67

69

70

74

78

81

82

92

93

93

95

95

96

97

98

99

100

26

53

58

63

69

71

72

75

79

82

82

93

93

95

96

90

92

94

96

98

100

27

52

56

63

70

74

74

78

81

82

84

93

95

95

90

90

92

94

96

98

100

28

52

56

64

71

75

77

79

82

85

86

95

90

92

92

94

95

97

97

98

100

29

51

56

64

71

78

78

81

84

86

88

95

90

90

92

92

94

95

97

98

100

30

51

56

64

72

79

79

82

85

88

89

90

90

92

93

93

94

96

97

99

100

31

51

56

64

72

78

81

84

84

88

84

90

90

92

93

93

94

96

97

99

100

32

51

56

64

71

78

81

85

86

84

85

90

90

92

94

93

94

96

97

99

100

33

51

57

62

71

78

82

85

83

84

85

90

92

93

93

93

94

96

97

99

100

34

51

56

62

71

78

82

81

83

85

86

90

92

92

94

93

94

96

97

99

100

35

51

56

62

71

78

79

83

84

85

86

90

91

91

93

93

94

96

97

99

100

36

49

56

62

71

74

79

83

84

85

86

90

90

91

93

92

94

95

97

98

100

37

48

55

62

67

74

79

83

84

85

86

89

90

89

92

91

93

95

96

98

100

38

47

55

57

66

72

77

81

84

86

86

87

88

88

90

91

93

95

96

98

100

39

45

50

57

66

72

77

81

83

85

86

86

87

86

89

90

92

94

96

98

100

40

41

50

57

66

72

77

81

83

84

85

86

86

86

89

89

91

93

96

98

100

 


Female, Smoker

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

41

40

50

57

65

71

76

79

81

83

84

85

85

85

89

90

92

94

96

98

100

42

40

49

57

65

69

74

77

80

82

83

84

85

86

90

92

94

95

97

98

100

43

39

49

55

63

69

73

76

78

80

82

83

84

85

92

93

94

96

97

99

100

44

39

48

55

62

67

71

75

78

80

80

82

84

86

93

96

97

98

98

99

100

45

37

47

55

61

65

70

73

76

78

80

81

84

86

94

97

98

98

99

99

100

46

36

46

53

59

63

68

71

75

77

79

83

85

86

93

96

97

98

98

99

100

47

34

44

51

57

62

66

70

75

77

80

83

85

86

93

94

95

96

98

99

100

48

34

44

50

54

60

64

69

74

77

80

84

86

87

92

92

94

95

97

98

100

49

33

42

48

53

58

63

68

74

77

81

84

86

87

92

91

93

95

96

98

100

50

31

41

46

51

57

61

67

74

77

81

85

87

87

91

90

92

94

96

98

100

51

30

39

45

51

56

61

67

74

75

80

83

85

85

90

90

92

94

96

98

100

52

29

38

45

50

56

62

68

74

75

79

81

83

84

90

90

92

94

96

100

100

53

28

37

43

49

57

62

68

73

74

77

79

81

83

89

89

91

93

100

100

100

54

28

36

43

49

57

63

69

73

74

75

78

80

81

87

89

91

100

100

100

100

55

26

35

42

49

57

63

69

73

73

74

76

78

79

86

87

100

100

100

100

100

56

26

35

42

49

56

62

67

71

72

74

76

78

79

85

100

100

100

100

100

100

57

26

35

42

49

55

61

66

69

72

73

76

78

79

100

100

100

100

100

100

100

58

28

36

43

49

55

59

63

68

69

72

76

78

100

100

100

100

100

100

100

100

59

28

36

43

49

54

57

63

67

68

70

76

100

100

100

100

100

100

100

100

100

60

28

36

43

49

53

57

61

64

67

69

100

100

100

100

100

100

100

100

100

100

61

26

35

42

48

52

56

59

63

66

80

100

100

100

100

100

100

100

100

100

100

62

26

33

41

47

51

55

58

62

80

80

100

100

100

100

100

100

100

100

100

100

63

25

33

41

46

51

55

57

80

80

80

100

100

100

100

100

100

100

100

100

100

64

25

33

40

45

50

53

80

80

80

80

100

100

100

100

100

100

100

100

100

100

65

24

32

39

44

49

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

66

24

32

39

44

72

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

67

24

32

39

72

72

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

68

24

32

68

72

72

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

69

24

64

68

72

72

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

70

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

 


Female, Smoker

Issue                          Duration

Age

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20+

71

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

72

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

73

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

74

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

75

60

60

64

68

68

72

75

75

80

80

100

100

100

100

100

100

100

100

100

100

76

60

60

64

68

68

72

75

75

80

100

100

100

100

100

100

100

100

100

100

100

77

60

60

64

68

68

72

75

75

100

100

100

100

100

100

100

100

100

100

100

100

78

60

60

64

68

68

72

75

100

100

100

100

100

100

100

100

100

100

100

100

100

79

60

60

64

68

68

72

100

100

100

100

100

100

100

100

100

100

100

100

100

100

80

60

60

64

68

68

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

81

60

60

64

68

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

82

60

60

64

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

83

60

60

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

84

60

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

85+

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

100

 

 


 

PART Ins 3507  RECOGNITION OF THE 2001 CSO MORTALITY TABLE FOR USE IN DETERMINING MINIMUM RESERVE LIABILITIES AND NONFORFEITURE BENEFITS

 

Statutory Authority:  RSA 400-A:15; RSA 409:5-b, VIII(f)

 

          Ins 3507.01  Purpose.  The purpose of this part is to recognize, permit, and prescribe the use of the 2001 Commissioners' Standard Ordinary (CSO) Mortality Table in accordance with RSA 410:3, I, RSA 409:5-b, VIII(f), Ins 3504.01, and Ins 3504.02.

 

Source.  #8144, eff 9-1-04; ss by #10194, eff 10-1-12; ss by #13471, eff 10-24-22

 

          Ins 3507.02  Definitions Used in This Part.

 

          (a)  "2001 CSO Mortality Table" means that mortality table, consisting of separate rates of mortality for male and female lives, developed by the American Academy of Actuaries CSO Task Force from the Valuation Basic Mortality Table developed by the Society of Actuaries Individual Life Insurance Valuation Mortality Task Force, and adopted by the National Association of Insurance Commissioners (NAIC) in December 2002.  The 2001 CSO Mortality Table is included in the proceedings of the NAIC (2nd Quarter 2002).  Unless the context indicates otherwise, the "2001 CSO Mortality Table" includes both the ultimate form of that table and the select and ultimate form of that table and includes both the smoker and nonsmoker mortality tables and the composite mortality tables.  It also includes both the age-nearest-birthday and age-last-birthday bases of the mortality tables.

 

          (b)  "2001 CSO Mortality Table (F)" means that mortality table consisting of the rates of mortality for female lives from the 2001 CSO Mortality Table.

 

          (c)  "2001 CSO Mortality Table (M)" means that mortality table consisting of the rates of mortality for male lives from the 2001 CSO Mortality Table.

 

          (d)  "Composite mortality tables" means mortality tables with rates of mortality that do not distinguish between smokers and nonsmokers.

 

          (e)  "Smoker and nonsmoker mortality tables" means mortality tables with separate rates of mortality for smokers and nonsmokers.

Source.  #8144, eff 9-1-04; ss by #10194, eff 10-1-12; ss by #13471, eff 10-24-22

 

          Ins 3507.03  2001 CSO Mortality Table.

 

          (a)  At the election of the company for any one or more specified plans of insurance and subject to the conditions stated in this rule, the 2001 CSO Mortality Table may be used as the minimum standard for policies issued on or after January 1, 2005 and before the date specified in (b) to which RSA 410:3, I, RSA 409:5-b, VIII(f), Ins 3504.01, and Ins 3504.02 are applicable.  If the company elects to use the 2001 CSO Mortality Table, it shall do so for both valuation and nonforfeiture purposes.

 

          (b)  Subject to the conditions stated in this rule, the 2001 CSO Mortality Table shall be used in determining minimum standards for policies issued on and after January 1, 2009, to which RSA 410:3, I, RSA 409:5-b, VIII(f), Ins 3504.01, and Ins 3504.02 are applicable.

 

Source.  #8144, eff 9-1-04; ss by #10194, eff 10-1-12; ss by #13471, eff 10-24-22

 

                  Ins 3507.04  Conditions.

 

          (a)  For each plan of insurance with separate rates for smokers and nonsmokers an insurer may use:

 

(1)  Composite mortality tables to determine minimum reserve liabilities and minimum cash surrender values and amounts of paid-up nonforfeiture benefits;

 

(2)  Smoker and nonsmoker mortality tables to determine the valuation net premiums and additional minimum reserves, if any, required by RSA 410:7 and use composite mortality tables to determine the basic minimum reserves, minimum cash surrender values and amounts of paid-up nonforfeiture benefits; or

 

(3)  Smoker and nonsmoker mortality to determine minimum reserve liabilities and minimum cash surrender values and amounts of paid-up nonforfeiture benefits.

 

          (b)  For plans of insurance without separate rates for smokers and nonsmokers the composite mortality tables shall be used.

 

          (c)  For the purpose of determining minimum reserve liabilities and minimum cash surrender values and amounts of paid-up nonforfeiture benefits, the 2001 CSO Mortality Table may, at the option of the company for each plan of insurance, be used in its ultimate or select and ultimate form, subject to the restrictions of Ins 3505.01 through Ins 3505.08 relative to use of the select and ultimate form.

 

          (d)  When the 2001 CSO Mortality Table is the minimum reserve standard for any plan for a company, the actuarial opinion in the annual statement filed with the commissioner shall be based on an asset adequacy analysis as specified in Ins 2401.05.  The commissioner may exempt a company from this requirement if it only does business in this state and in no other state.

 

Source.  #8144, eff 9-1-04; ss by #10194, eff 10-1-12; ss by #13471, eff 10-24-22

 

          Ins 3507.05  Applicability of the 2001 CSO Mortality Table.

 

          (a)  The 2001 CSO Mortality Table may be used in the following manner, subject to the transition dates for use of the 2001 CSO Mortality Table in Ins 3507.03:

 

(1)  Ins 3502.01 (a)(1)b.2.:  The net level reserve premium is based on the ultimate mortality rates in the 2001 CSO Mortality Table.

 

(2)  Ins 3503.01 (b):  All calculations are made using the 2001 CSO Mortality Rate, and, if elected, the optional minimum mortality standard for deficiency reserves stipulated in Ins 3507.05 (a)(4).  The value of "qx+k+t-1" is the valuation mortality rate for deficiency reserves in policy year k+t, but using the unmodified select mortality rates if modified select mortality rates are used in the computation of deficiency reserves.

 

(3)  Ins 3504.01:  The 2001 CSO Mortality Table is the minimum standard for basic reserves.

 

(4)  Ins 3504.02:  The 2001 CSO Mortality Table is the minimum standard for deficiency reserves.  If select mortality rates are used, they may be multiplied by X percent for durations in the first segment, subject to the conditions specified in Ins 3504.02 (a)(3).  In demonstrating compliance with those conditions, the demonstrations may not combine the results of tests that utilize the 1980 CSO Mortality Table with those tests that utilize the 2001 CSO Mortality Table, unless the combination is explicitly required by rule or necessary to be in compliance with relevant Actuarial Standards of Practice.

 

(5)  Ins 3505.03:  The valuation mortality table used in determining the tabular cost of insurance shall be the ultimate mortality rates in the 2001 CSO Mortality Table.

 

(6)  Ins 3505.05 (a)(4):  The calculations specified in Ins 3505.05 shall use the ultimate mortality rates in the 2001 CSO Mortality Table.

 

(7)  Ins 3505.06 (a)(4):  The calculations specified in Ins 3505.06 shall use the ultimate mortality rates in the 2001 CSO Mortality Table.

 

(8)  Ins 3505.07 (a)(2):  The calculations specified in Ins 3505.07 shall use the ultimate mortality rates in the 2001 CSO Mortality Table.

 

(9)  Ins 3506.01 (a)(2):  The one-year valuation premium shall be calculated using the ultimate mortality rates in the 2001 CSO Mortality Table.

 

          (b)  Nothing in this section shall be construed to expand the applicability of Ins 3500 to include life insurance policies exempted under Ins 3502.01.

 

Source.  #8144, eff 9-1-04; ss by #10194, eff 10-1-12; ss by #13471, eff 10-24-22

 

          Ins 3507.06  Gender-Blended Tables.

 

          (a)  For any ordinary life insurance policy delivered or issued for delivery in this state on and after January 1, 2005, that utilizes the same premium rates and charges for male and female lives or is issued in circumstances where applicable law does not permit distinctions on the basis of gender, a mortality table that is a blend of the 2001 CSO Mortality Table (M) and the 2001 CSO Mortality Table (F) may, at the option of the company for each plan of insurance, be substituted for the 2001 CSO Mortality Table for use in determining minimum cash surrender values and amounts of paid-up nonforfeiture benefits.  No change in minimum valuation standards is implied by this subsection of the rule.

 

          (b)  The company may choose from among the blended tables developed by the American Academy of Actuaries CSO Task Force and adopted by the NAIC in December 2002.

 

          (c)  It shall not, in and of itself, be a violation of RSA 417 for an insurer to issue the same kind of policy of life insurance on both a sex-distinct and sex-neutral basis.

 

Source.  #8144, eff 9-1-04; ss by #10194, eff 10-1-12; ss by #13471, eff 10-24-22

 

 

          Ins 3507.07  Waiver or Suspension of Rules.

 

          (a)  The commissioner, upon the commissioner’s own initiative or upon request by an insurer, shall waive any requirement of this chapter if such waiver does not contradict the objective or intent of the rule and: 

 

(1)  Applying the rule provision would cause confusion or would be misleading to consumers;

 

(2)  The rule provision is in whole or in part inapplicable to the given circumstances;

 

(3)  There are specific circumstances unique to the situation such that strict compliance with the rule would be onerous without promoting the objective or intent of the rule provision; or

 

(4)  Any other similar extenuating circumstances exist such that application of an alternative standard or procedure better promotes the objective or intent of the rule provision.

 

          (b)  No requirement prescribed by statute shall be waived unless expressly authorized by law.

 

          (c)  Any person or entity seeking a waiver shall make a request in writing to the commissioner.

 

          (d)  A request for a waiver shall specify the basis for the waiver and proposed alternative, if any.

 

          (e)  Waivers that are granted shall be in effect for the period of time requested and approved by the commissioner.

 

Source.  #13471, eff 10-24-22

 

 

PART Ins 3508  PERMITTING THE RECOGNITION OF PREFERRED MORTALITY TABLES FOR USE IN DETERMINING MINIMUM RESERVE LIABILITIES

 

Statutory Authority:  RSA 400-A;15, I.; RSA 409:5-b VIII. (f); RSA 410:2-a

 

          Ins 3508.01  Purpose.  The purpose of this part is to recognize, permit and prescribe the use of mortality tables that reflect differences in mortality between preferred and standard lives in determining minimum reserve liabilities in accordance with RSA 410:3, I., RSA 409:5-b, VIII. (f), Ins 3504.01 and Ins 3504.02.

 

Source.  #8886, eff 6-1-07; ss by #10879, eff 7-10-15

 

          Ins 3508.02  Definitions.

 

          (a)  "2001 CSO Mortality Table" means that mortality table, consisting of separate rates of mortality for male and female lives, developed by the American Academy of Actuaries CSO Task Force from the Valuation Basic Mortality Table developed by the Society of Actuaries Individual Life Insurance Valuation Mortality Tax Force, and adopted by the National Association of Insurance Commissioners (NAIC) in December 2002.  The 2001 CSO Mortality Table is included in the proceedings of the NAIC (2nd Quarter 2002) and supplemented by the 2001 CSO Preferred Class Structure Mortality Table defined in (b) below. Unless the context indicates otherwise, the "2001 CSO Mortality Table" includes both the ultimate form of that table and the select and ultimate form of that table and includes both the smoker and nonsmoker mortality tables and the composite mortality tables.  It also includes both the age-nearest-birthday and age-last-birthday bases of the mortality tables. Mortality tables in the 2001 CSO Mortality Table include the following:

 

(1)  "2001 CSO Mortality Table (F)" means that mortality table consisting of the rates of mortality for female lives from the 2001 CSO Mortality Table.

 

(2)  "2001 CSO Mortality Table (M)" means that mortality table consisting of the rates of mortality for male lives from the 2001 CSO Mortality Table.

 

(3)  "Composite mortality tables" means mortality tables with rates of mortality that do not distinguish between smokers and nonsmokers.

 

(4)  "Smoker and nonsmoker mortality tables" means mortality tables with separate rates of mortality for smokers and nonsmokers.

 

          (b)  "2001 CSO Preferred Class Structure Mortality Table" means mortality tables with separate rates of mortality for super preferred nonsmokers, preferred nonsmokers, residual standard nonsmokers, preferred smokers, and residual standard smoker splits of the 2001 CSO Nonsmoker and Smoker tables, as adopted by the NAIC at the September, 2006 national meeting and published in the NAIC Proceedings [3rd Quarter 2006].  Unless the context indicates otherwise, the "2001 CSO Preferred Class Structure Mortality Table" includes both the ultimate form of that table and the select and ultimate form of that table.  It includes both the smoker and nonsmoker mortality tables.  It includes both the male and female mortality tables and the gender composite mortality tables.  It also includes both the age-nearest-birthday and age-last-birthday bases of the mortality table.

 

          (c)  "Statistical agent" means an entity with proven systems for protecting the confidentiality of individual insured and insurer information; demonstrated resources for and history of ongoing electronic communications and data transfer ensuring data integrity with insurers, which are its members or subscribers; and a history of and means for aggregation of data and accurate promulgation of the experience modifications in a timely manner.

 

Source.  #8886, eff 6-1-07; ss by #10879, eff 7-10-15

 

          Ins 3508.03  2001 CSO Preferred Class Structure Table.  At the election of the company, for each calendar year of issue, for any one or more specified plans of insurance and subject to satisfying the conditions stated in this part, the 2001 CSO Preferred Class Structure Mortality Table may be substituted in place of the 2001 CSO Smoker or Nonsmoker Mortality Table as the minimum valuation standard for policies issued on or after January 1, 2007.  For policies issued on or after September 1, 2004, and prior to January 1, 2007, these tables may be substituted with the consent of the commissioner and subject to the conditions of Ins 3508.04.  In determining such consent, the commissioner may rely on the consent of the commissioner of the company’s state of domicile.  No such election shall be made until the company demonstrates at least 20 percent of the business to be valued on this table is in one or more of the preferred classes. A table from the 2001 CSO Preferred Class Structure Mortality Table used in place of a 2001 CSO Mortality Table, pursuant to the requirements of this part, will be treated as part of the 2001 CSO Mortality Table only for purposes of reserve valuation pursuant to the requirements of Ins 3507 Recognition of the 2001 CSO Mortality Table for Use in Determining Minimum Reserve Liabilities and Nonforfeiture Benefits.

 

Source.  #8886, eff 6-1-07; ss by #10879, eff 7-10-15

 

          Ins 3508.04  Conditions.

 

          (a)  For each plan of insurance with separate rates for preferred and standard nonsmoker lives, an insurer may use the super preferred nonsmoker, preferred nonsmoker, and residual standard nonsmoker tables to substitute for the nonsmoker mortality table found in the 2001 CSO Mortality Table to determine minimum reserves.  At the time of election and annually thereafter, except for business valued under the residual standard nonsmoker table, the appointed actuary shall certify that:

 

(1)  The present value of death benefits over the next 10 years after the valuation date, using the anticipated mortality experience without recognition of mortality improvement beyond the valuation date for each class, is less than the present value of death benefits using the valuation basic table corresponding to the valuation table being used for that class.

 

(2)  The present value of death benefits over the future life of the contracts, using anticipated mortality experience without recognition of mortality improvement beyond the valuation date for each class, is less than the present value of death benefits using the valuation basic table corresponding to the valuation table being used for that class.

 

          (b)  For each plan of insurance with separate rates for preferred and standard smoker lives, an insurer may use the preferred smoker and residual standard smoker tables to substitute for the smoker mortality table found in the 2001 CSO Mortality Table to determine minimum reserves.  At the time of election and annually thereafter, for business valued under the Preferred Smoker Table, the appointed actuary shall certify that:

 

(1)  The present value of death benefits over the next 10 years after the valuation date, using the anticipated mortality experience without recognition of mortality improvement beyond the valuation date for each class, is less than the present value of death benefits using the preferred smoker valuation basic table corresponding to the valuation table being used for that class.

 

(2)  The present value of death benefits over the future life of the contracts, using anticipated mortality experience without recognition of mortality improvement beyond the valuation date for each class, is less than the present value of death benefits using the preferred smoker valuation basic table.

 

          (c)  Unless exempted by the commissioner, every authorized insurer using the 2001 CSO Preferred Class Structure Table shall annually file with the commissioner, with the NAIC, or with a statistical agent designated by the NAIC and acceptable to the commissioner, statistical reports showing mortality and such other information as the commissioner may deem necessary or expedient for the administration of the provisions of this part.  The form of the reports shall be established by the commissioner or the commissioner may require the use of a form established by the NAIC or by a statistical agent designated by the NAIC and acceptable to the commissioner.

 

          (d)  The use of the 2001 Preferred Class Structure Table for the valuation of policies issued prior to January 1, 2007 shall not be permitted in any statutory financial statement in which a company reports, with respect to any policy or portion of a policy coinsured, either of the following:

 

(1)  In cases where the mode of payment of the reinsurance premium is less frequent than the mode of payment of the policy premium, a reserve credit that exceeds, by more than the amount specified in this paragraph as Y, the gross reserve calculated before reinsurance.  Y is the amount of the gross reinsurance premium that:

 

a.  Provides coverage for the period from the next policy premium due date to the earlier of the end of the policy year and the next reinsurance premium due date; and

 

b.  Would be refunded to the ceding entity upon the termination of the policy.

 

(2)  In cases where the mode of payment of the reinsurance premium is more frequent than the mode of payment of the policy premium, a reserve credit that is less than the gross reserve, calculated before reinsurance, by an amount that is less than the amount specified in this paragraph as Z.  Z is the amount of the gross reinsurance premium that the ceding entity would need to pay the assuming company to provide reinsurance coverage from the period of the next reinsurance premium due date to the next policy premium due date minus any liability established for the proportionate amount not remitted to the reinsurer.

 

          (e)  For purposes of this condition (d), the reserve for the:

 

(1)  Mean reserve method shall be defined as the mean reserve minus the deferred premium asset, and

 

(2)  Mid-terminal reserve methods shall include the unearned premium reserve.

 

          (f)  A company may estimate and adjust its accounting on an aggregate basis in order to meet the conditions to use the 2001 CSO Preferred Class Structure Table.

 

Source.  #8886, eff 6-1-07; ss by #10879, eff 7-10-15

 

PART Ins 3509 Preneed Life Insurance Minimum Standards for Determining Reserve Liabilities and Nonforfeiture Values

 

Statutory Authority:  RSA 400-A;15, I., RSA 409:5-b(f); RSA 410:2-a

 

          Ins 3509.01  Purpose.  The purpose of this part is to establish for preneed insurance products minimum mortality standards for reserves and nonforfeiture values, and to require the use of the 1980 Commissioners Standard Ordinary (CSO) Life Valuation Mortality Table for use in determining the minimum standard of valuation of reserves and the minimum standard nonforfeiture values for preneed insurance products.

 

Source.  #9245, eff 9-2-08; ss by #11148, eff 9-2-16

 

          Ins 3509.02  Applicability and Scope.  This section applies to preneed insurance contracts, as defined in Ins 3509.03, and to similar policies and certificates.

 

Source.  #9245, eff 9-2-08; ss by #11148, eff 9-2-16

 

          Ins 3509.03  Definitions.  For the purposes of this section:

 

          (a)  "2001 CSO Mortality Table" means that mortality table, consisting of separate rates of mortality for male and female lives, developed by the American Academy of Actuaries CSO Task Force from the Valuation Basic Mortality Table developed by the Society of Actuaries Individual Life Insurance Valuation Mortality Task Force, and adopted by the NAIC in December 2002.  The 2001 CSO Mortality Table is included in the Proceedings of the NAIC (2nd Quarter 2002) and as referenced in Appendix B.  Unless the context indicates otherwise, the "2001 CSO Mortality Table" includes both the ultimate form of that table and the select and ultimate form of that table and includes both the smoker and nonsmoker mortality tables and the composite mortality tables.  It also includes both the age-nearest-birthday and the age-last-birthday bases of the mortality tables.

 

          (b)  "Ultimate 1980 CSO" means the Commissioners' 1980 Standard Ordinary life Valuation Mortality Tables (1980 CSO) without 10-year selection factors, incorporated into the 1980 amendments to the NAIC Standard Valuation Law approved in December 1983 and as referenced in Appendix B.

 

          (c)  "Preneed insurance" means any life insurance policy or certificate that is issued in combination with, in support of, with an assignment to, or as a guarantee for a prearrangement agreement for goods and services to be provided at the time of and immediately following the death of the insured.  Goods and services may include, but are not limited to embalming, cremation, body preparation, viewing or visitation, coffin or urn, memorial stone, and transportation of the deceased.  The status of the policy or contract as preneed insurance is determined at the time of issue in accordance with the policy form filing.

 

Source.  #9245, eff 9-2-08; ss by #11148, eff 9-2-16

 

          Ins 3509.04  Minimum Valuation Mortality Standards.  For preneed insurance contracts as defined in Ins 3905.03 (c), and similar policies and contracts, the minimum mortality standard for determining reserve liabilities and non-forfeiture values for both male and female insureds shall be the Ultimate 1980 CSO.

 

Source.  #9245, eff 9-2-08; ss by #11148, eff 9-2-16

 

          Ins 3509.05  Minimum Valuation Interest Rate Standards.

 

          (a)  The interest rates used in determining the minimum standard for valuation of preneed insurance shall be the calendar year statutory valuation interest rates as defined in RSA 410.

 

          (b)  The interest rates used in determining the minimum standard for nonforfeiture values for preneed insurance shall be the calendar year statutory nonforfeiture interest rates as defined in RSA 409.

 

Source.  #9245, eff 9-2-08; ss by #11148, eff 9-2-16

 

          Ins 3509.06  Minimum Valuation Method Standards.

 

          (a)  The method used in determining the standard for the minimum valuation of reserves of preneed insurance shall be the method defined in RSA 410.

 

          (b)  The method used in determining the standard for the minimum nonforfeiture values for preneed insurance shall be the method defined in RSA 409.

 

Source.  #9245, eff 9-2-08; ss by #11148, eff 9-2-16

 

          Ins 3509.07  Transition Rules.

 

          (a)  For preneed insurance policies issued on or after September 2, 2008 and before January 1, 2012, the 2001 CSO may be used as the minimum standard for reserves and minimum standard for non-forfeiture benefits for both male and female insureds.

 

          (b)  If an insurer elects to use the 2001 CSO as a minimum standard for any policy issued on or after September 2, 2008 and before January 1, 2012, the insurer shall provide, as a part of the actuarial opinion memorandum submitted in support of the company's asset adequacy testing, an annual written notification to the domiciliary commissioner.  The notification shall include:

 

(1) A complete list of all preneed forms that use the 2001 CSO as a minimum standard;

 

(2)  A certification signed by the appointed actuary stating that the reserve methodology employed by the company in determining reserves for the preneed policies issued after the effective date and using the 2001 CSO as a minimum standard, develops adequate reserves.  For the purposes of this certification, the preneed insurance policies using the 2001 CSO as a minimum standard shall not be aggregated with any other policies; and

 

(3)  Supporting information regarding the adequacy of reserves for preneed insurance policies issued after September 2, 2008 and using the 2001 CSO as a minimum standard for reserves.

 

          (c)  Preneed insurance policies issued on or after January 1, 2012, shall use the Ultimate 1980 CSO in the calculation of minimum nonforfeiture values and minimum reserves.

 

Source.  #9245, eff 9-2-08; ss by #11148, eff 9-2-16


Appendix A- Statutes Implemented

 

Rule

Specific State or Federal Statutes or Regulations the Rule Implements

 

 

Ins 3501.01

RSA 400-A:15, I; 410:3; 408:33

Ins 3502.01

RSA 400-A:15, I; 410:2; 408:33

Ins 3503.01

RSA 400-A:15, I; 410:2, 408:33

Ins 3504.01

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3504.02

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3504.03

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3505.01

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3505.02

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3505.03

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3505.04

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3505.05

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3505.06

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3505.07

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3505.08

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3506.01

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3506.02

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3506.03

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3506.04

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 408:33

Ins 3507.01

RSA 400-A:15; 410:3; RSA 408:33; RSA 409:5-b, VIII(f)(1)-(2)

Ins 3507.02

RSA 410:2; RSA 408:33; RSA 409:5-b; RSA 409:5-c; RSA 409:6-a

Ins 3507.03

RSA 410:4; RSA 410:5; RSA 410:7; RSA 408:33; 409:5-b; 409:5-c; RSA 409:6-a

Ins 3507.04

RSA 410:4; RSA 410:5; RSA 410:7; RSA 408:33; RSA 409:5-b; RSA 409:5-c;

RSA 409:6-a

Ins 3507.05

RSA 410:4; RSA 410:5; RSA 410:7; RSA 408:33; RSA 409:5-b; RSA 409:5-c;

RSA 409:6-a

Ins 3507.06

RSA 410:4; RSA 410:5; RSA 410:7; RSA 408:33; RSA 409:5-b; RSA 409:5-c;

RSA 409:6-a

Ins 3507.07

RSA 400-A:15

Ins 3508.01

RSA 400-A:15, I.; 410:3, VIII.; 408:33; 409:5-b, VIII. (f)

Ins 3508.02

RSA 410:2; 408:33; 409:5-b; 409:5-c; 409:6-a

Ins 3508.03

RSA 410:4; 410:5; 410:6; 410:7; 408:33; 409:5-b; 409:5-c; 409:6-a

Ins 3508.04

RSA 410:4; 410:5; 410:6; 410:7; 408:33; 409:5-b; 409:5-c; 409:6-a

Ins 3509.01

RSA 400-A:15, I; 409; 410

Ins 3509.02

RSA 400-A:15, I; 410:2; 409:2; 409:5-b; 409:5-c; 409:6-a

Ins 3509.03

RSA 400-A:15, I; 410:4; 410:5; 410:6; 410:7; 409:2; 409:5-b; 409:5-c; 409:6-a

Ins 3509.04

RSA 400-A:15, I; 410:2; 410:4; 410:5; 410:6; 410:7;  409:5-b; 409:5-c; 409:6-a

Ins 3509.05

RSA 400-A:15, I; 410:2; 410:3-b; 410:4; 410:5; 410:6; 410:7;  409:5-b; 409:5-c; 409:6-a

Ins 3509.06

RSA 400-A:15, I; 410:2; 410:4; 410:5; 410:6; 410:7;  409:5-b; 409:5-c; 409:6-a

Ins 3509.07

RSA 400-A:15, I; 409:5-a; 409:5-b; 409:5-c; 409:6; 409:6-a; 409:8; 410:3-a; 410:3-b

 


APPENDIX B

Incorporation by Reference Information

 

 

Rule

Title

Obtain at:

Ins 3502.01(a)(1)b.2; 3503.01(b); 3503.01(f);  3504.01(a); 3504.02(a); 3505.05(a)(4); 3505.06(a)(4); 3505.07(a)(2); 3506.01(a)(2)

1980 Commissioners’ Standard Ordinary Mortality Table (1980 CSO Table) developed by the Society of Actuaries

Published by Society of Actuaries

Available for no cost at: http://mort.soa.org/

Ins 3504.02(a)(3)i.2

Actuarial Standards of Practice Developed by the Actuarial Standards Board

Published by the Actuarial Standards Board

Available for no cost at:

http://www.actuarialstandardsboard.org/

standards-of-practice/

Ins 3504.01(a)(1); 3504.02(a)(1); 3505.03

Standard Valuation Law adopted by the National Association of Insurance Commissioners (NAIC) in 1980

Published by the NAIC

Available for no cost at:

http://www.naic.org/store/free/MDL-820.pdf

 

Ins 3509.01;

Ins 509.03(b);

Ins 3509.04;

Ins 3509.07(c)

Ultimate 1980 CSO

On-line, for no cost:

http://www.nh.gov/insurance/legal/documents/1980_cso_table_1980_cet_tbl.pdf

Ins 3509.03(a); Ins 3509.07

2001 CSO Mortality Table

On-line, for no cost:  http://www.nh.gov/insurance/legal/documents/2001_cso_2002_naic_proc1153.pdf